AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 23 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $625 | +55.5% | 1,391,381 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $402 | -35.7% | 1,391,381 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $625 | -99.7% | 1,391,381 | +196.9% | 0.00% | +200.0% |
| Q3 2022 | $245,000 | +17.8% | 468,558 | +13.3% | 0.00% | 0.0% |
| Q2 2022 | $208,000 | -39.2% | 413,387 | +176.7% | 0.00% | 0.0% |
| Q1 2022 | $342,000 | -44.8% | 149,399 | +14.2% | 0.00% | -50.0% |
| Q4 2021 | $620,000 | +798.6% | 130,835 | +1426.7% | 0.00% | – |
| Q1 2019 | $69,000 | -86.7% | 8,570 | -84.2% | 0.00% | -100.0% |
| Q3 2018 | $519,000 | -32.9% | 54,230 | -25.8% | 0.00% | -33.3% |
| Q2 2018 | $773,000 | +151.8% | 73,100 | +136.9% | 0.00% | +200.0% |
| Q1 2018 | $307,000 | +468.5% | 30,860 | +206.4% | 0.00% | – |
| Q4 2017 | $54,000 | +145.5% | 10,073 | +121.2% | 0.00% | – |
| Q3 2017 | $22,000 | +1000.0% | 4,554 | +840.9% | 0.00% | – |
| Q4 2016 | $2,000 | – | 484 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,291,151 | $8,844,000 | 3.78% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 335,279 | $2,297,000 | 2.84% |
| Abingworth LLP | 240,500 | $1,638,000 | 0.63% |
| Nantahala Capital Management | 2,852,260 | $19,538,000 | 0.60% |
| RITHOLTZ WEALTH MANAGEMENT | 290,534 | $1,990,000 | 0.34% |
| Orbimed Advisors | 2,165,524 | $14,834,000 | 0.23% |
| Rock Springs Capital Management LP | 800,000 | $5,480,000 | 0.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 187,206 | $1,282,000 | 0.18% |
| Leap Investments LP | 16,600 | $114,000 | 0.15% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 500,046 | $3,425,000 | 0.12% |